Mark Robertshaw

Mark Robertshaw practices at Texas Health Plano in Plano, Texas, part of Texas Health Resources.

Mark Robertshaw's NPI, 1396277265, was assigned on March 30, 2017. Mark Robertshaw graduated from University of Missouri School of Medicine in 2017. Mark Robertshaw holds Texas license S6924.

Mark Robertshaw's primary practice is Texas Health Plano, at 6200 W Parker Rd, Plano, TX 75093 in Collin County. The practice phone is (972) 981-8000.

Mark Robertshaw's primary practice is Texas Health Plano in Plano, Texas, part of Texas Health Resources. Mark Robertshaw is also affiliated with Texas Health Presbyterian Hospital Allen. The medical group on file is Cogent HMG. Dmand AI also links Mark Robertshaw to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Robertshaw practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Mark Robertshaw's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Mark Robertshaw is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Mark Robertshaw's licenses on file in 2 states: Texas and North Carolina.

Dmand AI lists aneurysm, atrial fibrillation and flutter, chronic hypertension and chronic obstructive pulmonary disease (COPD) among the conditions Mark Robertshaw treats.

CMS data shows 746 Medicare services from Mark Robertshaw across 10 procedure codes in 2024, for 324 Medicare patients. Medicare paid $65,444 for them.

CMS counts 324 Medicare patients who saw Mark Robertshaw in 2024. The largest group is 75 to 84, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Robertshaw's median patient age at 67, with 47% women.

In 2024, Mark Robertshaw wrote 206 Medicare Part D claims for 57 patients. 54% of them were for generic drugs. CMS names the drug for 74 of them, across 5 drugs with 11 or more claims each, at $15,135 in total drug cost. In 2023, CMS named 63 claims across 3 drugs.

Mark Robertshaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mark Robertshaw as offering telehealth.

Dmand AI links 4 papers to Mark Robertshaw, published from 2011 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Alveolitis, Extrinsic Allergic. Mark Robertshaw has published most often in PLoS One. Mark Robertshaw's most frequent co-authors are Traci N. Adams, MD, Craig Steven Glazer, MD and Kiran Batra, MD.

CMS Open Payments shows 57 general payments to Mark Robertshaw from 19 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $265.

Mark Robertshaw graduated from University of Missouri School of Medicine in 2017.

Mark Robertshaw is in network with 17 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Aetna. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.